Accelerating Paediatric and Maternity Health: Insights from i4KIDS and i4KIDS-EUROPE
Discover about the projects, activities, and proposals of i4KIDS and i4KIDS-EUROPE and the insights of our White Paper.

Discover more about the projects, activities, and proposals of i4KIDS and i4KIDS-EUROPE, as well as the current state of innovation in paediatric and maternal health in Europe.
Additionally, we will explore the strategic actions presented in our White Paper, aimed at overcoming the barriers affecting the development of innovation in Europe.
🎤 Speakers:
✅ Arnau Valls Esteve – Sant Joan de Déu Barcelona Children’s Hospital
✅ Charlotte Bertaud – EIT Health Spain
✅ Guillem Figueras Manzanares – Inveniam Group
✅ Ilona Platonova – Bērnu klīniskā universitātes slimnīca
Related News

Featured
i4KIDS has completed its first season of collaboration with RNE's Cuídate programme, featuring nine episodes focused on paediatric and foetal health innovation. The series brought together healthcare professionals, researchers and innovators to discuss advances in areas such as rare diseases, paediatric haematology, prematurity, neurodevelopment, congenital heart disease and paediatric palliative care.

Featured
i4KIDS is reinforcing its commitment to innovation in paediatric, fetal and maternal health by collaborating in two strategic initiatives currently open for applications: CRAASH Barcelona 2026 and DKV Challenge 2026. Both programmes offer new opportunities for startups and innovative projects seeking to accelerate the development, validation and adoption of solutions with an impact on maternal and child health.

Uncategorized
i4KIDS and Catalonia.Health brought together startup leaders, researchers and healthcare professionals to discuss funding, regulatory strategy and international growth. The session featured Gisela Lorente (Aptadel Therapeutics), Marc Martinell (Minoryx Therapeutics) and Stefanos Theoharis (OneChain Immunotherapeutics), highlighting Barcelona's growing role as a leading hub for paediatric health innovation.